This inventor holds 1 USPTO granted patent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2026
Title: Lining Zhu Hutchinson and Liposomal Chemotherapy
Introduction
Lining Zhu Hutchinson is an inventor based in Duarte, California. His work includes a patent describing liposomal formulations for intraperitoneal chemotherapy, an approach intended to deliver chemotherapeutic agents into the peritoneal cavity.
Latest Patents
Hutchinson is associated with 1 patent, titled “Liposomal Enhanced Intra-Peritoneal Chemotherapy.” The patent describes methods for treating neoplasms by administering liposomal formulations of taxane or platin chemotherapeutic agents into the peritoneal cavity. The disclosed methods include treatment of ovarian cancer and primary peritoneal cancer.
The formulations include a taxane, such as paclitaxel or docetaxel, or a platin agent, together with two phospholipids: dipalmitoyl phosphatidylcholine (DMPC) and dimyristoyl phosphatidyl glycerol sodium (DMPG).
Career Highlights
The patent highlights Hutchinson’s contribution to research on drug-delivery formulations for cancer treatment. Its focus is the intraperitoneal administration of liposomal chemotherapy agents for cancers affecting the peritoneal cavity.
Collaborations
Natarajan Venkatesan and Teresa B. Hong are identified as Hutchinson’s coworkers in connection with this work.
Conclusion
Lining Zhu Hutchinson’s patent documents a liposomal approach to delivering chemotherapy within the peritoneal cavity, with applications described for ovarian and primary peritoneal cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile